The industrial equipment maker's shares fell after Baird cut its rating to Neutral and slashed its price target, warning that new regulations on data center construction could slow future orders. The move follows a separate downgrade earlier in the week, adding to investor concerns ahead of the company's earnings report.
Procter & Gamble shares declined after the consumer goods giant reported fiscal fourth-quarter results that missed Wall Street estimates for gross margin and EBITDA, coupled with a 1% drop in sales volumes.
The medical device maker surpassed Wall Street's second-quarter expectations for profit and revenue, driven by strong sales in its imaging and diagnostics units and a $129 million tariff reimbursement. The news eased investor concerns about a potential slowdown in medical procedures, sending shares higher.
IT services giant Cognizant projected third-quarter revenue below analyst estimates and trimmed its full-year forecast, citing continued caution from clients on discretionary technology spending.
Shares of Parsons Corp. dropped sharply after the defense and engineering firm reported a significant second-quarter earnings miss driven by large contract-related charges and issued a revenue forecast that fell short of analyst expectations.
SoFi Technologies reported record loan originations, membership, and revenue for the second quarter, yet shares fell in a 'sell the news' reaction. Investors are now focused on the execution risk associated with the company's ambitious second-half margin targets.
Shares of Verra Mobility (VRRM) soared after the company secured a new seven-year service agreement with Avis Budget Group, despite disclosing that the commercial terms are less favorable than the previous contract.
The gene therapy company reported second-quarter revenue of $5.80 million, exceeding analyst expectations. A recent $259 million follow-on offering has secured its funding for operations into 2030.
Shares of United Microelectronics fell in pre-market trading as investors focused on valuation concerns and a bearish analyst outlook, overshadowing a robust second-quarter financial report.
